Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2017-04-16 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
独立董事关于调整发行股份购买资产及重大资产出售暨关联交易方案的独立意见
Capital/Financing Update Classification · 95% confidence The document is an independent opinion from the independent directors of Chengdu Tianxing Instrument Co., Ltd. regarding an adjustment to a share issuance purchase of assets and a major asset sale and related party transaction plan. It discusses details of share transfers, adjustments to the transaction counterparties, and compliance with relevant laws and regulations. The document is not a full financial report, earnings release, or regulatory filing but rather an opinion on a specific transaction adjustment. It is related to a capital transaction involving issuance of shares for asset purchase and major asset sale, which fits the Capital/Financing Update category. The document length is under 5,000 characters, but it contains substantive content about the transaction adjustment, not just an announcement of a report publication. Therefore, the best classification is Capital/Financing Update (CAP).
2017-04-16 Chinese
关于全资子公司增资完成工商变更登记的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the completion of a capital increase and related business registration changes for a wholly-owned subsidiary. It details board and shareholder meeting approvals and the completion of the capital increase registration with the local market supervision authority. The document is short (923 characters) and primarily serves as a formal announcement of a corporate action (capital increase and registration update). It does not contain financial statements, detailed financial analysis, or comprehensive report content. Therefore, it is best classified as a Capital/Financing Update (CAP).
2017-04-16 Chinese
中信建投证券股份有限公司关于公司调整发行股份购买资产及重大资产出售暨关联交易方案之独立财务顾问核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed independent financial advisor's verification opinion regarding adjustments to a share issuance for asset purchase and major asset sale transaction involving Chengdu Tianxing Instrument Co., Ltd. It discusses the transaction scheme, adjustments, share transfer details, compliance with regulatory requirements, and approvals by the board and supervisory committee. The document is not a full annual or interim report, nor is it a simple announcement. It is a standalone audit or verification report related to a specific transaction and regulatory compliance, submitted to the China Securities Regulatory Commission. The content aligns with an Audit Report / Information (AR) filing, as it provides an independent financial advisor's verification opinion on a major asset transaction and related share issuance adjustments, including compliance with laws and regulations, but does not contain full financial statements or earnings data typical of Annual or Interim Reports. Q1 2017
2017-04-16 Chinese
第七届监事会第六次临时会议决议公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement of resolutions from the Supervisory Board meeting of Chengdu Tianxing Instrument Co., Ltd. It discusses adjustments to a major asset purchase and sale transaction involving issuance of shares to acquire 100% equity of another company, Beijing Berry and Kang Biotechnology Co., Ltd. The document includes detailed terms of the transaction, pricing, share issuance, lock-up periods, and related agreements. It also references compliance with the relevant Chinese company law and securities regulations. The content is focused on a capital transaction involving issuance of shares to purchase assets and a major asset sale, with detailed terms and approvals. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes through issuance of shares for acquisition and asset sale. The document is not a full annual or interim report, nor an earnings release or management discussion. It is not a proxy or voting result announcement, nor a regulatory filing or legal proceeding report. Therefore, the best classification is CAP with high confidence.
2017-04-16 Chinese
中信建投证券股份有限公司关于公司发行股份购买资产及重大资产出售暨关联交易之独立财务顾问报告
Audit Report / Information Classification · 95% confidence The document is titled as an "Independent Financial Advisor Report" related to a major asset purchase and sale transaction involving Chengdu Tianxing Instrument Co., Ltd. It includes detailed sections on the transaction background, company information, asset details, evaluation, risk factors, and advisor opinions. The content is comprehensive and focused on a significant asset restructuring and related financial advisory opinions. This matches the characteristics of an Audit Report / Information (AR) as it is a standalone report providing professional financial advisory and evaluation related to a major asset transaction, rather than a full annual report or a simple announcement. The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement. Therefore, the appropriate classification is AR with high confidence. FY 2016
2017-04-16 Chinese
发行股份购买资产及重大资产出售暨关联交易报告书（草案）修订稿摘要
Capital/Financing Update Classification · 95% confidence The document is a detailed report concerning the issuance of shares to purchase assets and a major asset sale, including related party transactions. It includes extensive financial data, transaction details, valuation reports, and compliance analysis. The content focuses on a significant corporate restructuring involving asset acquisition and disposal, with detailed financial and legal disclosures. This matches the characteristics of a Capital/Financing Update (CAP) filing, which covers company fundraising, financing activities, or capital structure changes. The document is not a simple announcement but a comprehensive report on the transaction. Therefore, the appropriate classification is CAP.
2017-04-16 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.